Generex Biotechnology Corporation Aktie
Aktien
A2DL9M
US3714853013
GNBT
Biotechnologie
Manager | Titel | Alter | Seit |
---|---|---|---|
Joseph Moscato
CEO | Chief Executive Officer | 61 | 21.11.17 |
Mark Carrao
DFI | Director of Finance/CFO | - | 01.01.17 |
Terry Thompson
COO | Chief Operating Officer | 65 | 25.06.18 |
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Brian T. McGee
BRD | Director/Board Member | 63 | 01.03.04 |
Eric von Hofe
PRN | Corporate Officer/Principal | 66 | 01.01.05 |
Craig Eagle
BRD | Director/Board Member | 57 | 21.11.17 |
% 1. Jan. | Kap. | |
---|---|---|
-3.30% | 102 Mrd. | |
+1.79% | 96.07 Mrd. | |
-1.34% | 21.66 Mrd. | |
-18.35% | 20.77 Mrd. | |
-8.58% | 18.53 Mrd. | |
-40.31% | 16.91 Mrd. | |
-26.84% | 13.79 Mrd. | |
+0.59% | 13.33 Mrd. | |
+20.86% | 10.94 Mrd. |